Pappagallo, G., & Rizzo, M. (2014). Directness and quality of evidence of bevacizumab combined with chemotherapy for platinum-resistant, recurrent ovarian cancer in the AURELIA trial:  . Cancer Breaking News, 2(2), 39–41. Retrieved from https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/274